🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also receiving discount codes.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where communities with numerous of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Concerns

However, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in individuals administering products of uncertain source.

Several experts stated the popularity for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, legal action or prison.

Service Response and Content Elimination

According to the social media company, the service has taken down problematic content and prohibited related hashtags and search suggestions. The organization said it was dedicated to keeping the platform secure and investing in enhancing compliance measures.

Digital Trading Activities

Research also discovered communities with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, positive reviews and step-by-step instructions for mixing or administering at residence.

After moments of entering one group, a seller posted WhatsApp details, where the majority of transactions take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Within these communities, posts show black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service stated it regularly moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they cannot confirm. Although the science behind this drug is sound, these online versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has previously encountered patients injured by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational product not yet approved … may expose patients to potentially serious medical dangers”.